Flavonoids and Platelet-Derived Thrombotic Disorders

Curr Med Chem. 2019;26(39):7035-7047. doi: 10.2174/0929867325666180417170218.


Thrombotic disorders are characterized by an increase in the probability of the formation of unnecessary thrombi that might be due to the activation of the coagulation cascade or the circulating platelets. Platelets or thrombocytes play an essential role in hemostasis but abnormal platelet function leads to the development of a number of cardiovascular complications, including thrombotic disorders. Under pathological conditions, platelets are associated with the development of different thrombotic disorders, including atherosclerosis, arterial thrombosis and stroke, deep venous thrombosis and pulmonary embolism; therefore, platelets are the target of a number of anti-thrombotic strategies. Flavonoids, a large group of polyphenols ubiquitously expressed in fruits and vegetables that have attracted considerable attention because of their benefits in human health, including the reduction of the risk of cardiovascular disease. Flavonoids have been reported to reduce platelet activity by attenuating agonist-induced GPIIb/IIIa receptor activation, mobilization of intracellular free Ca2+, granule exocytosis, as well as activation of different signaling molecules such as mitogen- activated protein kinases or phospholipases. This review summarizes the current studies concerning the modulation of platelet activation by flavonoids, giving especial attention to those events associated to thrombotic disorders.

Keywords: GPIIb/IIIa receptor; Platelets; anti-thrombotic strategies; cardiovascular disease; flavonoids; thrombotic disorders..

Publication types

  • Review

MeSH terms

  • Animals
  • Cardiovascular Agents / pharmacology*
  • Cardiovascular Diseases / drug therapy*
  • Flavonoids / pharmacology*
  • Humans
  • Platelet Activation / drug effects*
  • Thrombosis / drug therapy*


  • Cardiovascular Agents
  • Flavonoids